Skip to main content
NRC
NASDAQ Industrial Applications And Services

Founder-Related Entities Register to Sell 14.5M Shares, 64% of Outstanding Stock

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
9
Price
$18.52
Mkt Cap
$420.76M
52W Low
$11.014
52W High
$22.79
Market data snapshot near publication time

summarizeSummary

Entities related to NRC Health's founder have registered to sell 14.5 million shares, representing 64% of outstanding stock, creating a substantial market overhang as the company receives no proceeds.


check_boxKey Events

  • Massive Share Offering Registered

    Selling shareholders, primarily founder-related entities, have registered to sell 14,524,566 shares of common stock.

  • Significant Market Overhang

    The shares offered represent approximately 64.45% of the company's 22,536,696 outstanding common shares, creating a substantial potential increase in market supply.

  • No Company Proceeds

    NRC Health will not receive any funds from these sales, as they are secondary offerings by existing shareholders.

  • Founder-Related Sales

    The selling shareholders are identified as various LLCs and irrevocable trusts, many with names linked to the founder's family, and the filing notes these are for 'estate planning transactions and prior sales'.


auto_awesomeAnalysis

This filing details the potential sale of a massive block of shares by entities related to NRC Health's founder, Michael D. Hays. The 14.5 million shares represent approximately 64% of the company's outstanding stock and could introduce a significant supply overhang on the market. The company will not receive any proceeds from these sales, which are described as related to estate planning and prior transactions. This follows a previous 13D/A filing where the founder reduced his beneficial ownership, indicating a continued reduction in the founder's family's stake.

At the time of this filing, NRC was trading at $18.52 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $420.8M. The 52-week trading range was $11.01 to $22.79. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed NRC - Latest Insights

NRC
May 13, 2026, 4:09 PM EDT
Filing Type: 424B7
Importance Score:
9
NRC
May 08, 2026, 9:44 AM EDT
Filing Type: DEF 14A
Importance Score:
8
NRC
May 06, 2026, 11:51 AM EDT
Source: Wiseek News
Importance Score:
9
NRC
May 06, 2026, 11:42 AM EDT
Filing Type: 10-Q
Importance Score:
7
NRC
Apr 28, 2026, 5:19 PM EDT
Filing Type: PRE 14A
Importance Score:
8
NRC
Apr 28, 2026, 5:16 PM EDT
Filing Type: 10-K/A
Importance Score:
8
NRC
Apr 28, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
NRC
Apr 28, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
7
NRC
Apr 20, 2026, 5:07 PM EDT
Filing Type: 8-K
Importance Score:
7
NRC
Mar 27, 2026, 4:35 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9